Clinical Trial Update: Intratympanic Injection of Dexamethasone With Hyaluronic Acid in Treatment of Sudden Sensorineural Hearing Loss [Phase 4]

View source ↗

Summary

An update on a Phase 4 clinical trial evaluating intratympanic dexamethasone with hyaluronic acid for sudden sensorineural hearing loss, currently not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sudden Sensorineural Hearing Loss

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Hyaluronic acid (hyaluronic acid)

Snippet

Sponsor: Assiut University | Conditions: Sudden Sensorineural Hearing Loss (SSNHL) | Phase 4 | Status: NOT_YET_RECRUITING